Ativan Injection (lorazepam injection, USP), 2mg/mL, 1 mL vial, 25 vials per car Supply Disruption — Hikma Pharmaceuticals USA Inc
Ativan Injection (lorazepam injection, USP), 2mg/mL, 1 mL vial, 25 vials per car Supply Disruption — Hikma Pharmaceuticals USA Inc is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: Ativan Injection (lorazepam injection, USP), 2mg/mL, 1 mL vial, 25 vials per car; Manufacturer: Hikma
| Drug name | Ativan Injection (lorazepam injection, USP), 2mg/mL, 1 mL vial, 25 vials per car |
|---|---|
| Manufacturer | Hikma Pharmaceuticals USA Inc. |
| Recall/Disruption reason | Failed Impurities/Degradation Specifications: Out-of-specification results observed for total related compounds during t |
| Risk classification | Moderate Risk — Temporary Health Consequence |
| Status | Terminated |
| Record type | Enforcement/Recall |
| Recall number | D-1308-2022 |
| Initiation date | 20220711 |
| Quantity affected | 301,400 vials |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →